Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

Wyeth

MADISON, NJ US

1. 20090291971 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION 11-26-2009
2. 20090291079 TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS 11-26-2009
3. 20090287280 Portable moist heat system - portable moist heat delivery system comprising a water vapor generating portion comprising a water vapor source and a heat 11-19-2009
4. 20090287168 METHOD OF DELIVERING A SKIN BENEFIT - method of providing a skin benefit to the skin including the use of a skin care active and a portable moist heat 11-19-2009
5. 20090285827 ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8 ASSOCIATED DISORDERS 11-19-2009
6. 20090283106 METHOD OF DELIVERING A HAIR CARE BENEFIT 11-19-2009
7. 20090281096 CYCLOTHIOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS 11-12-2009
8. 20090281091 METHODS FOR MODULATING BLADDER FUNCTION - This invention provides methods and pharmaceutical compositions for modulating bladder function 11-12-2009
9. 20090271163 Crystal structure of human factor VIII and uses thereof 10-29-2009
10. 20090270447 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof 10-29-2009
11. 20090270363 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof 10-29-2009
12. 20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors 10-22-2009
13. 20090263817 METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE AND COMPOSITIONS THEREOF 10-22-2009
14. 20090253711 HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 10-08-2009
15. 20090246868 Serum-free vero cell banking process - provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine 10-01-2009
16. 20090246786 NOVEL RAT VOLTAGE-GATED POTASSIUM CHANNEL 10-01-2009
17. 20090239863 1-ARYL-OR 1- ALKYLSULFONYLBENZAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 09-24-2009
18. 20090239855 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders 09-24-2009
19. 20090221711 TRIFLUOROMETHYL-CONTAINING PHENYLSULFONAMIDE BETA AMYLOID INHIBITORS 09-03-2009
20. 20090220983 CELL-BASED METHODS FOR DETECTING AND/OR MEASURING BMP-12-RELATED PROTEIN ACTIVITY 09-03-2009
21. 20090220619 NUTRITIONAL FORMULATION - nutritional supplements that provide an adult with essential vitamins and minerals that may be lacking in the adult's diet and 09-03-2009
22. 20090215794 SEROTONERGIC AGENTS - Novel piperazine derivatives are provided having the formula STR00001 wherein R 08-27-2009
23. 20090215748 FXR agonists for treating vitamin D associated diseases 08-27-2009
24. 20090214513 MAMMALIAN EXPRESSION SYSTEMS - The present invention features mammalian expression systems with improved production yields and method of using these 08-27-2009
25. 20090209601 USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS 08-20-2009
26. 20090209527 Methods for Using Rapamycin Analogues in the Treatment of Neurological Disorders 08-20-2009
27. 20090203682 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological Disorders 08-13-2009
28. 20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease 08-13-2009
29. 20090197878 SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR 08-06-2009
30. 20090192176 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-30-2009
31. 20090192147 [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-30-2009
32. 20090186358 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof 07-23-2009
33. 20090186026 EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION 07-23-2009
34. 20090181963 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-16-2009
35. 20090181952 COMPOUNDS USEFUL AS ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS 07-16-2009
36. 20090181932 COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS 07-16-2009
37. 20090176969 CLONING GENES FROM STREPTOMYCES CYANEOGRISEUS SUBSP. NONCYANOGENUS FOR BIOSYNTHESIS OF ANTIBIOTICS AND METHODS OF USE 07-09-2009
38. 20090176884 PHARMACEUTICAL SUSPENSION COMPOSITION - aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase 07-09-2009
39. 20090176827 MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF 07-09-2009
40. 20090176819 39-Desmethoxy-39-Methyl Derivatives of Rapamycin 07-09-2009
41. 20090176764 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS 07-09-2009
42. 20090175906 Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof 07-09-2009
43. 20090175900 METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS 07-09-2009
44. 20090169584 Treatment of sleep disturbances - new composition for treating pain-associated sleep disturbances 07-02-2009
45. 20090163474 FXR Agonists for the Treatment of Nonalcoholic Fatty Liver and Cholesterol Gallstone Diseases 06-25-2009
46. 20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus 06-25-2009
47. 20090162321 METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN 06-25-2009
48. 20090156826 METHODS FOR THE PREPARATION OF HYDROXY-SUBSTITUTED ARYL SULFAMIDE COMPOUNDS 06-18-2009
49. 20090156537 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES 06-18-2009
50. 20090156462 USE OF FIBROUS TISSUE INDUCING PROTEINS FOR HERNIA REPAIR 06-18-2009
51. 20090155784 ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION 06-18-2009
52. 20090155353 MICROEMULSIONS FOR PHARMACEUTICAL COMPOSITIONS 06-18-2009
53. 20090155256 Immunotherapy Regimes Dependent On APOE Status 06-18-2009
54. 20090149458 PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS 06-11-2009
55. 20090148436 ANTIBODY TO GDF8 AND USES THEREOF - The disclosure provides novel molecules related to growth and differentiation factor-8 in particular epitopes 06-11-2009
56. 20090143577 PURIFICATION OF PROGESTERONE RECEPTOR MODULATORS 06-04-2009
57. 20090143345 THIOAMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS 06-04-2009
58. 20090142763 NESTED PCR-BASED METHOD FOR SPECIFIC GENOTYPING OF THE FC GAMMA RECEPTOR IIIA GENE 06-04-2009
59. 20090137554 1,4,5,6-TETRAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY 05-28-2009
60. 20090137516 COMPOSITIONS AND METHODS OF TREATING DYSLIPIDEMIA 05-28-2009
61. 20090131409 1,4,5,6,7,8-HEXAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY 05-21-2009
62. 20090130137 MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION 05-21-2009
63. 20090118276 THIENOPYRIMIDINES, THIENOPYRIDINES, AND PYRROLOPYRIMIDINES AS B-RAF INHIBITORS 05-07-2009
64. 20090117152 Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine 05-07-2009
65. 20090111867 INDOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOF 04-30-2009
66. 20090111802 CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS 04-30-2009
67. 20090105461 Calicheamicin conjugates - Anti-Lewis Y antibodies are described 04-23-2009
68. 20090105303 SULFONYL-3-HETEROCYCLYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 04-23-2009
69. 20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide 04-23-2009
70. 20090099376 TIGECYCLINE AND METHODS OF PREPARING INTERMEDIATES 04-16-2009
71. 20090099223 METHODS OF TREATING HORMONE-RELATED CONDITIONS USING THIO-OXINDOLE DERIVATIVES 04-16-2009
72. 20090099164 Phenylaminopropanol Derivatives and Methods of Their Use 04-16-2009
73. 20090099149 BIOADHESIVE FILM - s for delivery of active agent to the mucosa are disclosed 04-16-2009
74. 20090098577 METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE CASPASE 9 ACTIVITY VIA USE OF A KOSMOTROPIC SALT 04-16-2009
75. 20090098132 COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS 04-16-2009
76. 20090098086 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS 04-16-2009
77. 20090097026 COLOR MEASUREMENTS OF RECONSTITUTED TIGECYCLINE AND DEGRADANT THEREOF 04-16-2009
78. 20090093630 CHIRAL SYNTHESIS OF DIAZEPINOQUINOLINES - improved methods of resolution and recrystallization for synthesizing compounds useful as 5HT 04-09-2009
79. 20090093498 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE 04-09-2009
80. 20090088448 Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological Disorders 04-02-2009
81. 20090087433 ActRIIB Fusion Polypeptides and Uses Therefor 04-02-2009
82. 20090087431 METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL 04-02-2009
83. 20090087375 ActRIIB Fusion Polypeptides and Uses Therefor 04-02-2009
84. 20090082591 METHODS FOR PREPARING SULFONAMIDE COMPOUNDS 03-26-2009
85. 20090082434 Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same 03-26-2009
86. 20090082354 PYRAZOLO[5, 1-C] [1,2,4] TRIAZINES, METHODS FOR PREPARATION AND USE THEREOF 03-26-2009
87. 20090076077 Methods and Compositions for Selectin Inhibition 03-19-2009
88. 20090075283 Vectors and Methods for Cloning Gene Clusters or Portions Thereof 03-19-2009
89. 20090072189 METHOD OF MAKING HEAT CELLS COMPRISING EXOTHERMIC COMPOSITIONS HAVING ABSORBENT GELLING MATERIAL 03-19-2009
90. 20090069564 Methods and Compositions for Selectin Inhibition 03-12-2009
91. 20090069373 Quinoline Acids - This invention relates generally to quinoline-based modulators of Liver X receptors and related methods 03-12-2009
92. 20090069370 AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 03-12-2009
93. 20090069342 KV1.5 POTASSIUM CHANNEL INHIBITORS - 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1 03-12-2009
94. 20090069319 IMIDAZOPYRIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 03-12-2009
95. 20090069300 ISOQUINOLINYL AND ISOINDOLINYL DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 03-12-2009
96. 20090068705 Use of Copper Glutamate in Cell Culture for Production of Polypeptides 03-12-2009
97. 20090068232 ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS 03-12-2009
98. 20090068231 LIVE ATTENUATED MYCOPLASMA STRAINS - live attenuated Mycoplasma bacteria that exhibit reduced expression of one or more proteins selected from the group 03-12-2009
99. 20090062281 3-QUINOLINECARBONITRILE PROTEIN KINASE INHIBITORS 03-05-2009
100. 20090062131 NUCLEIC ACID ARRAYS FOR DETECTING GENE EXPRESSION IN ANIMAL MODELS OF INFLAMMATORY DISEASES 03-05-2009
101. 20090061423 PHARMACOGENOMIC MARKERS FOR PROGNOSIS OF SOLID TUMORS 03-05-2009
102. 20090061024 COMPOSITIONS AND METHODS EMPLOYING NMDA ANTAGONISTS FOR ACHIEVING AN ANESTHETIC-SPARING EFFECT 03-05-2009
103. 20090060906 Anti-IL-13 antibody formulations and uses thereof 03-05-2009
104. 20090054663 COUPLING PROCESS FOR GENERATING REACTIVE BORON-CONTAINING DERIVATIVES OF N-SUBSTITUTED PYRROLE-2-CARBONITRILES TO PRODUCE BIARYLS 02-26-2009
105. 20090054484 SUBSTITUTED HETEROARYL BENZOFURAN ACIDS - generally to substituted heteroaryl benzofuran acids and methods of using them 02-26-2009
106. 20090054392 NAPHTHYLPYRIMIDINE, NAPHTHYLPYRAZINE AND NAPHTHYLPYRIDAZINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 02-26-2009
107. 20090054244 Nucleic acid molecule encoding a novel estrogen receptor beta variant 02-26-2009
108. 20090048286 Inhibitors of Protein Tyrosine Phosphatase 1B 02-19-2009
109. 20090048282 PYRIMIDINE SULFONAMIDE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 02-19-2009
110. 20090047287 MODULATION OF BONE FORMATION - This invention relates to modulating Ror activity and/or 14-3-3 02-19-2009
111. 20090042964 AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS 02-12-2009
112. 20090042912 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE 02-12-2009
113. 20090042908 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR BETA-SECRETASE MODULATION 02-12-2009
114. 20090042895 Antidepressant Piperidine Derivatives of Heterocycle-Fused Benzodioxans 02-12-2009
115. 20090036458 ENDOPARASITICIDAL TOPICAL COMPOSITIONS - composition which comprises: an effective amount of praziquantel and a second endoparasiticidal agent selected 02-05-2009
116. 20090036439 3-ARYL-4-HYDROXYFURANONE COMPOUNDS AND THE HUMAN AND ANIMAL HEALTH USE THEREOF 02-05-2009
117. 20090035807 ANALYSIS OF POLYPEPTIDE PRODUCTION - methods of evaluating a process to produce a polypeptide preparation or evaluating an element of a process to 02-05-2009
118. 20090029426 PROCESS FOR PREPARING RAPAMYCIN 42-ESTERS AND FK-506 32-ESTERS WITH DICARBOXYLIC ACID, PRECURSORS FOR RAPAMYCIN CONJUGATES AND ANTIBODIES 01-29-2009
119. 20090029382 CHARACTERIZATION OF A MEMBRANE ESTROGEN RECEPTOR 01-29-2009
120. 20090029366 METHODS OF IDENTIFYING MODULATORS OF HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED (HCN) CHANNELS 01-29-2009
121. 20090023930 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF HETEROCYCLIC SULFONAMIDE COMPOUNDS 01-22-2009
122. 20090023925 N'-(2-HALOBENZYLIDENE)SULFONYLHYDRAZIDES AS INTERMEDIATES IN THE MANUFACTURE OF ARYLSULFONYLINDAZOLES 01-22-2009
123. 20090023905 Transgenic animal model of bone mass modulation 01-22-2009
124. 20090023903 PROCESS FOR THE PREPARATION OF TRIFLUOROALKYL-PHENYL AND HETEROCYCLIC SULFONAMIDES 01-22-2009
125. 20090023801 INHIBITORS OF BETA AMYLOID PRODUCTION - Novel sulfonamide compounds useful in the treatment of conditions related to the production of beta-amyloid are 01-22-2009
126. 20090023707 AMINOALKYLAZOLE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 01-22-2009
127. 20090022753 Surface proteins of streptococcus pyogenes 01-22-2009
128. 20090022731 Arthritis-associated B cell gene expression 01-22-2009
129. 20090018365 Methods for Preparing O-Desmethylvenlafaxine 01-15-2009
130. 20090018332 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors 01-15-2009
131. 20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine 01-15-2009
132. 20090017460 DIFFERENTIAL EXPRESSION PROFILING ANALYSIS OF CELL CULTURE PHENOTYPES AND USES THEREOF 01-15-2009
133. 20090017067 EMULSION VACCINE COMPOSITIONS COMPRISING ANTIGEN AND ADJUVANT IN THE AQUEOUS PHASE 01-15-2009
134. 20090017064 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus 01-15-2009
135. 20090012308 PROCESS FOR THE MANUFACTURE OF BENZYLSULFONYLARENES 01-08-2009
136. 20090012139 AMINO-5-[4-(DIFLUOROMETHOXY) PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE 01-08-2009
137. 20090012095 HUMAN N-TYPE CALCIUM CHANNEL BLOCKERS - This invention features a method for modulating human N-type calcium channel 01-08-2009
138. 20090012053 Use of LXR agonists for the treatment of osteoarthritis 01-08-2009
139. 20090010963 Raccoon Poxvirus Expressing Rabies Glycoproteins 01-08-2009
140. 20080319204 PROCESS FOR THE SYNTHESIS OF PROGESTERONE RECEPTOR MODULATORS 12-25-2008
141. 20080319046 SUBSTITUTED SULFONAMIDE-INDOLES - generally to substituted sulfonamide indoles such as substituted sulfonamide indoles, and methods of using them 12-25-2008
142. 20080319011 PROTEIN TYROSINE KINASE ENZYME INHIBITORS 12-25-2008
143. 20080318971 TREATMENT OF IMATINIB RESISTANT LEUKEMIA 12-25-2008
144. 20080318921 Tricyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors 12-25-2008
145. 20080317776 Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor 12-25-2008
146. 20080312422 PROCESSES FOR MAKING HYDRAZIDES - method is disclosed for preparing hydrazides from hydrazine and an acyl chloride which comprises the steps of 12-18-2008
147. 20080312308 SUBSTITUTED ACETIC ACID DERIVATIVES - generally to substituted acetic acid derivatives and methods of using them 12-18-2008
148. 20080312306 POLYMORPHS, SOLVATES, AND HYDRATE OF 5-(4'-FLUORO-2'-OXO-1',2'-DIHYDROSPIRO[CYCLOPROPANE-1,3'-INDOL]-5'-YL)-1-METHYL-1H-PYRROLE-2-CARBONITRILE 12-18-2008
149. 20080312203 Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors 12-18-2008
150. 20080311113 METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE 12-18-2008
151. 20080306138 STABLE NON-AQUEOUS POUR-ON COMPOSITIONS - stable antiparasitic non-aqueous pour-on parasiticidal composition which comprises an effective amount of 12-11-2008
152. 20080306131 Progesterone receptor modulator and uses thereof 12-11-2008
153. 20080306106 1-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 12-11-2008
154. 20080306091 AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION 12-11-2008
155. 20080300235 FXR Agonists for Reducing LOX-1 Expression 12-04-2008
156. 20080299668 DETECTION AND QUANTITATION OF CALICHEAMICIN 12-04-2008
157. 20080299149 Raccoon Poxvirus Expressing Genes of Feline Antigens 12-04-2008
158. 20080299141 Raccoon Poxvirus Expressing Genes of Porcine Virus 12-04-2008
159. 20080299118 FXR Agonists for the Treatment of Malignancies 12-04-2008
160. 20080293790 SUBSTITUTED ARYL OXIMES - and methods of using them 11-27-2008
161. 20080293771 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 11-27-2008
162. 20080293722 Ion Channel Modulators - compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions 11-27-2008
163. 20080293688 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-27-2008
164. 20080293583 Methods for diagnosing mood disorders - generally to the fields of neuroscience, proteomics and mood disorders 11-27-2008
165. 20080287452 HETEROARYL/ARYL PYRIMIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 11-20-2008
166. 20080287424 AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS 11-20-2008
167. 20080286838 SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES 11-20-2008
168. 20080280894 DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-13-2008
169. 20080280893 SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-13-2008
170. 20080280774 Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia 11-13-2008
171. 20080279874 COMPOSITIONS AND METHODS FOR MODULATION OF PLK1 KINASE ACTIVITY 11-13-2008
172. 20080275073 CRYSTALLINE FORMS AND POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS PHARMACEUTICALLY ACCEPTABLE SALTS 11-06-2008
173. 20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster 11-06-2008
174. 20080269333 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS 10-30-2008
175. 20080269321 Therapeutic Combinations for the Treatment or Prevention of Depression 10-30-2008
176. 20080269213 8-Hydroxyquinoline compounds and methods thereof 10-30-2008
177. 20080268460 Assays to Identify Irreversibly Binding Inhibitors of Receptor Tyrosine Kinases 10-30-2008
178. 20080262228 Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof 10-23-2008
179. 20080262010 CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS D-GLUCORONATE SALTS 10-23-2008
180. 20080262009 CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS ACETATE SALTS 10-23-2008
181. 20080262008 CRYSTALLINE FORMS AND POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS SUCCINATE SALTS 10-23-2008
182. 20080255192 Methods and Compositions for Selectin Inhibition 10-16-2008
183. 20080255177 ANTI-TUMOR ACTIVITY OF CCI-779 IN PAPILLARY RENAL CELL CANCER 10-16-2008
184. 20080255102 Phenylaminopropanol Derivatives and Methods of Their Use 10-16-2008
185. 20080255100 INDOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOF 10-16-2008
186. 20080254119 Imbedded liquid lubricants for tableting 10-16-2008
187. 20080249150 HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION CONTAINING AN AZOLE 10-09-2008
188. 20080249148 Synthesis and characterization of polymorph form III 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile 10-09-2008
189. 20080249124 WORTMANNIN-RAPALOG CONJUGATE AND USES THEREOF 10-09-2008
190. 20080249123 WORTMANNIN-RAPAMYCIN CONJUGATE AND USES THEREOF 10-09-2008
191. 20080242700 Methods and Compositions for Selectin Inhibition 10-02-2008
192. 20080241192 Vaccination against multiple serotypes of pasteurella multocida 10-02-2008
193. 20080241129 ADIPOCYTE SECRETED PROTEIN CCDC80 IS A POTENT STIMULATOR OF BONE FORMATION 10-02-2008
194. 20080234340 Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrile 09-25-2008
195. 20080234262 PYRAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS 09-25-2008
196. 20080233127 IMIDAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS PI3 KINASE AND MTOR INHIBITORS 09-25-2008
197. 20080227850 USE OF NOREPINEPHRINE REUPTAKE MODULATORS FOR PREVENTING AND TREATING VASOMOTOR SYMPTOMS 09-18-2008
198. 20080227207 AUTOMATED COLORIMETRIC POLYSACCHARIDE ASSAYS 09-18-2008
199. 20080226676 Multivalent avian influenza vaccines and methods 09-18-2008
200. 20080226645 Methods and compositions for assessment and treatment of asthma 09-18-2008
201. 20080221201 ARYL SULFONAMIDES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR 09-11-2008
202. 20080221193 3-AMINO CHROMANE DERIVATIVES - , to compositions containing such compounds 09-11-2008
203. 20080221160 SULFONYLATED HETEROCYCLES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR 09-11-2008
204. 20080221057 SECRETED PROTEIN CCDC80 REGULATES ADIPOCYTE DIFFERENTIATION 09-11-2008
205. 20080220094 Compositions and methods for the treatment and/or prevention of osteoporosis 09-11-2008
206. 20080214647 SUBSTITUTED INDOLE ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 09-04-2008
207. 20080213317 AVIAN E. COLI VACCINE FOR PROTECTION AGAINST COLIBACILLOSIS 09-04-2008
208. 20080207631 METHODS FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE CONDITIONS 08-28-2008
209. 20080200655 Protein Formulations Containing Sorbitol 08-21-2008
210. 20080200541 Benzofuranyl Alkanamine Derivatives and Uses Thereof 08-21-2008
211. 20080200381 Methods and compositions for regulating bone and cartilage formation 08-21-2008
212. 20080199534 Stability in vitamin and mineral supplements 08-21-2008
213. 20080199518 Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution 08-21-2008